TRITON and beyond: new insights into the profile of prasugrel.

Cardiovasc Ther · 2012 · PMC3440581 · PMID 21883999

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The prasugrel group showed a trend toward an increased risk of primary endpoint; however, this was not statistically significant [ 50 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.